Rigel Pharmaceuticals, Inc. (RIGL)
30.09
+0.61
(+2.07%)
USD |
NASDAQ |
May 28, 16:00
30.09
0.00 (0.00%)
After-Hours: 16:38
Rigel Pharmaceuticals Research and Development Expense (Annual) : 33.30M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc. | 10.25B |
| Arvinas, Inc. | 282.90M |
| Amgen, Inc. | 6.974B |
| Madrigal Pharmaceuticals, Inc. | 387.02M |
| Xencor, Inc. | 239.43M |